Allergenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.
Allergenis has raised $548K in total funding. The most recent round was Equity Crowdfunding. The last funding was announced in August 2023.
Allergenis's investors include Corporate Fuel.
Allergenis is headquartered in Hatfield, United States.
Allergenis is a develops precision, data-driven diagnostics to help healthcare providers more accurately and safely diagnose food allergy.
Allergenis is at the Equity Crowdfunding stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Allergenis — Funding & Investors." VCBacked, August 22, 2023, https://www.vcbacked.co/company/allergenis. Accessed August 16, 2026.
VCBacked. (2023). Allergenis — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/allergenis
{{cite web |title=Allergenis — Funding & Investors |url=https://www.vcbacked.co/company/allergenis |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated